Get started
Author

Changbin Zhu

Observed names: Chang-Bin Zhu, Zhu, Changbin
Observed institutions: BGI Group (China), Shanghai Jiao Tong University, XinHua Hospital, Erasmus MC, University Medical Center Utrecht, Xiamen Municipal Bureau of Science and Technology, Netherlands Heart Institute, Peking University People's Hospital, BGI Genomics
ORCID: 0009-0002-1762-5990
Observed ORCID: 0009-0002-1762-5990
OpenAlex ID: A5112575387
The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies
2017 · Changbin Zhu, Johan M Kros, et al. · Neuro-Oncology · 174
PDF
Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
2025 · Haiquan Chen, Chaoqiang Deng, et al. · Cancer Cell · 94
Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade
2017 · Changbin Zhu, Johan M. Kros, et al. · Acta Neuropathologica Communications · 80
PDF
CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions
2018 · Ihsan Chrifi, Laura Louzao-Martinez, et al. · Angiogenesis · 74
PDF
Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression
2016 · Changbin Zhu, Dana Mustafa, et al. · Neuro-Oncology · 73
Deciphering the Epitranscriptome in Cancer
2018 · Hao Lian, Qin-Hua Wang, et al. · Trends in cancer · 56
Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trial
2024 · Dawei Chen, Bing Zou, et al. · EClinicalMedicine · 43
Cgnl1, an endothelial junction complex protein, regulates GTPase mediated angiogenesis
2017 · Ihsan Chrifi, Dorien Hermkens, et al. · Cardiovascular Research · 40
PDF
Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high‐risk Chinese individuals
2019 · Di Shao, Shaomin Cheng, et al. · Cancer Science · 39
PDF
CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions
2017 · Ihsan Chrifi, Laura Louzao-Martinez, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 36
PDF
Integrating Histologic and Genomic Characteristics to Predict Tumor Mutation Burden of Early-Stage Non-Small-Cell Lung Cancer
2021 · Yuan Qiu, Liping Liu, et al. · Frontiers in Oncology · 35
PDF
Periostin Is Expressed by Pericytes and Is Crucial for Angiogenesis in Glioma
2020 · Karin Huizer, Changbin Zhu, et al. · Journal of Neuropathology & Experimental Neurology · 35
PDF
Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial
2024 · Xiao Han, Jun Guo, et al. · Signal Transduction and Targeted Therapy · 31
PDF
Concomitant Mutations in EGFR 19Del/L858R Mutation and Their Association with Response to EGFR-TKIs in NSCLC Patients
2020 · Hengrui Liang, Caichen Li, et al. · Cancer Management and Research · 24
PDF
Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre‐operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre
2017 · Tian Lv, Changbin Zhu, et al. · Clinical Endocrinology · 24
Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial
2022 · Xiao Han, Xiaoyong Tang, et al. · Journal for ImmunoTherapy of Cancer · 23
PDF
Genomic Scar Score: A robust model predicting homologous recombination deficiency based on genomic instability
2022 · Wuzhou Yuan, Jing Ni, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 23
Validation of a one-step genomics-based molecular classifier for endometrial carcinoma in a large Chinese population
2024 · Nan Kang, Xiaobo Zhang, et al. · Pathology - Research and Practice · 22
PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma
2022 · Jianhua Liu, Hao Chen, et al. · Cancer Immunology Immunotherapy · 21
Tumor microenvironment biomarkers predicting pathological response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma: post-hoc analysis of a single center, phase 2 study
2024 · Tingting Feng, Qian Li, et al. · Journal for ImmunoTherapy of Cancer · 19
PDF
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma
2024 · Yuxiang Ma, Huaqiang Zhou, et al. · npj Precision Oncology · 18
PDF
Association between homologous recombination deficiency status and carboplatin treatment response in early triple-negative breast cancer
2024 · Zheng Wang, Yujie Lu, et al. · Breast Cancer Research and Treatment · 15
Detecting ALK Rearrangement with RT-PCR: A Reliable Approach Compared with Next-Generation Sequencing in Patients with NSCLC
2021 · Yukun Kuang, Peihang Xu, et al. · Molecular Diagnosis & Therapy · 15
PDF
Incidence of metastatic disease and survival among patients with newly diagnosed primary CNS tumors in the United States from 2004-2013
2019 · Hao Lian, Craig Daniels, et al. · Journal of Cancer · 15
PDF
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance
2024 · Shengnan Chen, Tao Hu, et al. · npj Precision Oncology · 14
Works count: 100
Citation count: 1,209
H-index: 19
I10-index: 33
Year
Topic
Type